Home/ Supplements/ Lysine/ L-Lysine 500 mg

L-Lysine 500 mg

product on market Tablet or Pill Nature Made Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for L-Lysine 500 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

500 mg
Market median: 500.0mg (159 products)

Other Ingredients

Cellulose Gel Stearic Acid Methylcellulose Silicon Dioxide Croscarmellose Sodium Hypromellose Magnesium Stearate Polyethylene Glycol
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Take one tablet daily with a meal. For easier swallowing, take with water before and during ingestion.

Warnings & Precautions

Store in a cool, dry place, out of reach of children.

Do not use if imprinted seal under cap is broken or missing.

Formulation Notes

No color added No artificial flavors No preservatives No yeast Gluten free

Additional Information

List No. 1681 L200 Cat. 653 5A006

Actual size

Supports synthesis of proteins - L-Lysine, an essential amino acid, plays a key role in the makeup of body proteins.

Keep bottle tightly closed. Store in a cool, dry place, out of reach of children.

L-Lysine Tablets are made to Nature Made’s guaranteed purity and potency standards.

Metadata

Product Details

UPC / SKU0 31604 01681 4
DSLD Entry Date2018-07-25
Product TypeAmino acid/Protein
FormTablet or Pill
DSLD ID179509
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.